Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$118.38 - $210.04 $2.37 Million - $4.2 Million
20,000 New
20,000 $3.59 Million
Q4 2021

Feb 11, 2022

SELL
$225.82 - $368.51 $8.87 Million - $14.5 Million
-39,300 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$221.9 - $484.47 $12.6 Million - $27.5 Million
-56,700 Reduced 59.06%
39,300 $15.1 Million
Q2 2021

Aug 16, 2021

SELL
$129.91 - $234.98 $7.79 Million - $14.1 Million
-60,000 Reduced 38.46%
96,000 $22.6 Million
Q1 2021

May 17, 2021

BUY
$109.18 - $185.98 $10.5 Million - $17.9 Million
96,000 Added 160.0%
156,000 $20.4 Million
Q4 2020

Feb 16, 2021

BUY
$65.74 - $169.86 $1.64 Million - $4.25 Million
25,000 Added 71.43%
60,000 $6.27 Million
Q3 2020

Nov 16, 2020

BUY
$54.34 - $94.85 $1.9 Million - $3.32 Million
35,000 New
35,000 $2.48 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.